What is Xilio Development Inc (XLO) stock price today?

Xilio Development Inc (XLO) currently trades at $7.92 per share. The stock has a market capitalization of $45.80M and a P/E ratio of —x.

Is XLO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Xilio Development Inc has a Smart Value Score of 39/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Xilio Development Inc's revenue and earnings?

Xilio Development Inc has trailing twelve-month (TTM) revenue of $43.77M with profit margins of -80.00%. Earnings per share (EPS) is $-4.19.

XLO

Xilio Development Inc

NASDAQ: XLO · HEALTHCARE · BIOTECHNOLOGY

$7.92

+1.67% today

Updated 2026-04-30

Market cap

$45.80M

P/E ratio

—

P/S ratio

1.05x

EPS (TTM)

$-4.19

Dividend yield

—

52W range

$6 – $17

Volume

0.2M

Market cap

$45.80M

P/E ratio

—

P/S ratio

1.05x

EPS (TTM)

$-4.19

Dividend yield

—

52W range

$6 – $17

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

6.3

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$20.00

+152.53%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 694.00% QoQ

Risks

- Thin margins at -80.00%

- Negative free cash flow $-2.09M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$6.34M	$43.77M	$43.77M
Net income	$-87.30M	$-76.40M	$-58.24M	$-35.04M	$10.36M
EPS	—	—	—	—	$-4.19
Free cash flow	$-77.59M	$-69.11M	$-18.41M	$-5.51M	$-2.09M
Profit margin	—	—	-918.05%	-80.05%	-80.00%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
XLO	$45.80M	39	6.3	2.0	5.0	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Xilio Development Inc trades at $7.92. Our Smart Value Score of 39/100 indicates the stock is weak. TTM revenue stands at $43.77M. with profit margins at -80.00%.

Frequently asked questions

What is Xilio Development Inc's stock price?

Xilio Development Inc (XLO) trades at $7.92.

Is Xilio Development Inc overvalued?

Smart Value Score 39/100 (Grade D, Sell).

What is the price target of Xilio Development Inc (XLO)?

The analyst target price is $20.00, representing +152.5% upside from the current price of $7.92.

What is Xilio Development Inc's revenue?

TTM revenue is $43.77M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio1.05x

ROE-132.50%

Beta-0.12

50D MA$8.02

200D MA$9.47

Shares out0.01B

Float0.00B

Short ratio—

Avg volume0.2M

Performance

1 week-1.61%

1 month+1458.77%

3 months+1166.34%

YTD+1186.32%

1 year—

3 years—

5 years—

Compare

XLO vs LLY →XLO vs JNJ →XLO vs ABBV →Stock screener →